Edberg v. Neogen Corp.

17 F. Supp. 2d 104, 1998 U.S. Dist. LEXIS 12311, 1998 WL 458249
CourtDistrict Court, D. Connecticut
DecidedAugust 4, 1998
Docket3:98CV00717 (GLG)
StatusPublished
Cited by32 cases

This text of 17 F. Supp. 2d 104 (Edberg v. Neogen Corp.) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Edberg v. Neogen Corp., 17 F. Supp. 2d 104, 1998 U.S. Dist. LEXIS 12311, 1998 WL 458249 (D. Conn. 1998).

Opinion

OPINION

GOETTEL, District Judge.

This is a patent and trade dress infringement ease, in which the defendant, Neogen Corporation, has filed a motion to dismiss on the ground of lack of personal jurisdiction. Fed.R.Civ.P. 12(b)(2). Defendant, a foreign corporation, asserts that the requirements for personal jurisdiction have not been met by virtue of a single sale of its product in the forum state, which was orchestrated by the plaintiff, IDEXX Laboratories, Inc. It further asserts that its maintenance of a Web page on the Internet neither satisfies the requirements for personal jurisdiction under Connecticut’s long-arm statute nor meets the minimum contacts requirement of the Due Process Clause. After consideration of the parties’ submissions and after oral argument of counsel, this Court grants defendant’s motion to dismiss under Rule 12(b)(2), Fed.R.Civ.P. [Doc. # 17]. Accordingly, the Court denies defendant’s motion to transfer this matter to the Western District of Michigan [Doc. # 17] and denies plaintiffs’ motion to have this case reassigned to Judge Janet Bond Arterton, U.S.D.J., D. Conn. [Doc. #16].

Background

The Underlying Patents

This case involves patented products and devices used for the detection and quantification of certain microbiological pathogens, such as Escherichia coli (E.coli) and other related organisms, found in food and water. There are three patents at issue. Two are owned by plaintiffs, Drs. Edberg and Ward-law, professors at Yale University in New Haven, Connecticut. These patents are licensed to plaintiff IDEXX. The third is owned by IDEXX. The three patents, described in general terms, are as follows:

United States Patent No. 5,700,655 (the ’655 patent), entitled “Method for Quantification of Biological Material in a Sample,” covers a circular incubation plate having a multitude of recessed wells. The wells are designed to form separate incubation chambers that hold a portion of a liquid sample containing chemical or microbiological reagents. The plate is then incubated until the presence or absence of the biological material is determined. The plate is sterile and has a cover to prevent contamination of the sample. The named inventor on the patent is David E. Townsend, a research scientist with IDEXX.

United States Patent No. 4,925,789 (the ’789 patent), entitled “Method and Medium for Use in Detecting Target Microbes In Situ in a Specimen Sample of a Possibly Contaminated Material,” claims the microbiological medium used to test water samples for the presence of microorganisms, including E. coli and other coliforms. 1 It also claims methods of conducting tests using the medium, which contains a nutrient that can be significantly metabolized only by a target microorganism. A second reaction aecompa- *107 nies the metabolism of this specific nutrient and causes a “tell-tale” chemical or physical change in the medium (such as a change in color, which indicates the presence of coli-forms, or a fluorescence, which indicates the presence of E. coli), which is readily defecti-ble, thus indicating the presence of the target microorganism in the sample. 2 Dr. Edberg is the named inventor on this patent. United States Patent No. 5,429,933 (the ’933 patent), entitled “Detection of First Generation Environmental Sourced Microbes in an Environmentally-Derived Sample,” is a continuation in part of the ’789 patent and claims priority from the ’789 patent. Dr. Edberg is also the named inventor on this patent.

IDEXX manufactures and sells environmental diagnostic assay kits for E. coli and total coliforms under the trademarks Coli-lert® and Colisure®. These products are covered by the ’789 and ’933 patents. In addition, IDEXX manufactures and sells a diagnostic product line, consisting of an auto-aliquoting incubation vessel for the detection and quantification of total coliforms, E. coli, and other biological material under the trademark SimPlate®. This device is covered by the ’655 patent.

Defendant Neogen manufactures and sells a product under the registered trademark Reveal®, including the Reveal® Bio-Plate, which plaintiffs contend infringes the 655 patent, and Reveal® Bio-Plate Growth Medium, which plaintiffs allege infringes the ’789 and ’933 patents. Neogen’s Reveal® products are also used for the detection of total coliforms and E. coli, similar to IDEXX’s products. The Reveal® Bio-Plate is similar in appearance to IDEXX’s SimPlate®, although it is octagonal in shape.

The Jurisdictional Facts

Defendant Neogen is a Michigan corporation with its principal place of business in Lansing, Michigan. It is undisputed that Neogen has no property in Connecticut; it has no offices, distributors, employees, or agents in Connecticut; it has no personal property in Connecticut; and, it is not licensed to do business in the State of Connecticut. Nevertheless, plaintiffs attempt to assert personal jurisdiction over this nonresident defendant by virtue of its “doing business in Connecticut.” (Compl. at ¶ 3). Plaintiffs further assert that Neogen mass-produces, markets, and sells its Reveal® Bio-Plate products in interstate commerce throughout the United States. (Compl.lffl 19-20). Neogen denies that it does business in Connecticut, although it does admit that it had one sale in the amount of $246.00 to Cadbury-Schweppes in Trumbull, Connecticut in 1997 for a single order of its Reveal® Bio-Plates (a single order consists of 200 plates) and two containers of its Reveal® Bio-Plate Growth Medium. As discussed more fully below, Neogen maintains that this sale was orchestrated by IDEXX to attempt to establish personal jurisdiction over Neogen in Connecticut, as part of its forum-shopping activities. 3

With respect to the one admitted sale in Connecticut, Neogen asserts that it did not solicit this sale. Instead, it alleges that this order was placed by Cadbury-Schweppes at the behest of IDEXX, and that this was, in reality, a sale to IDEXX, which has its principal place of business in Maine. That the order was placed by Cadbury for IDEXX is not disputed. Neogen has produced the affidavit of Mr. Anthony Dworetsky of Cadbury, who testified that he was contacted by Mr. Lee Flores of IDEXX, who requested Dwor-etsky to contact Neogen and attempt to have it sell or ship to him in Connecticut its Reveal® Bio-Plate Multiple Test Medium, which Dworetsky did, in fact, do. Upon ob *108 taining the Reveal® products from Neogen, Dworetsky immediately shipped them to IDEXX in Maine. Thus, he says, the Neo-gen products remained in the State of Connecticut for less than one day.

The parties do dispute, however, why IDEXX asked Cadbury to place this order. Neogen asserts that IDEXX involved Cad-bury to provide a basis for in personam jurisdiction over Neogen as part of its forum-shopping efforts; IDEXX maintains that this was done to allow it to purchase a sample of the infringing products.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kindig It Design, Inc. v. Creative Controls, Inc.
157 F. Supp. 3d 1167 (D. Utah, 2016)
Larada Sciences, Inc. v. Skinner
147 F. Supp. 3d 1336 (D. Utah, 2015)
Petedge, Inc. v. Fortress Secure Solutions, LLC
144 F. Supp. 3d 249 (D. Massachusetts, 2015)
Frank Paterno v. Laser Spine Institute
23 N.E.3d 988 (New York Court of Appeals, 2014)
Mor-Dall Enterprises, Inc. v. Dark Horse Distillery, LLC
16 F. Supp. 3d 874 (W.D. Michigan, 2014)
Buccellati Holding Italia Spa v. Laura Buccellati, LLC
935 F. Supp. 2d 615 (S.D. New York, 2013)
OneBeacon Insurance Group v. Tylo AB
731 F. Supp. 2d 250 (D. Connecticut, 2010)
Grimaldi v. Guinn
72 A.D.3d 37 (Appellate Division of the Supreme Court of New York, 2010)
Preferred Display, Inc. v. Vincent Longo, Inc.
642 F. Supp. 2d 98 (D. Connecticut, 2009)
Chloé v. Queen Bee of Beverly Hills, LLC
571 F. Supp. 2d 518 (S.D. New York, 2008)
ISI Brands, Inc. v. KCC International, Inc.
458 F. Supp. 2d 81 (E.D. New York, 2006)
Elite Aluminum Corp. v. Trout
451 F. Supp. 2d 1311 (S.D. Florida, 2006)
Bathcrest, Inc. v. Safeway Safety Step, Inc.
417 F. Supp. 2d 1236 (D. Utah, 2006)
Atkinson v. McLaughlin
343 F. Supp. 2d 868 (D. North Dakota, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
17 F. Supp. 2d 104, 1998 U.S. Dist. LEXIS 12311, 1998 WL 458249, Counsel Stack Legal Research, https://law.counselstack.com/opinion/edberg-v-neogen-corp-ctd-1998.